877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

www.sigmaaldrich.com, Drugs acting on the genito-urinary system, CYP17A1 inhibitors, Anti-diabetic drugs, Six-membered rings, Hormonal agents

Categories

Antiandrogens (2)
Antiglucocorticoids (2)
Cyclic compounds (2)
Drugs acting on the gastrointestinal system and metabolism (2)
PPAR agonists (2)
Pharmaceuticals (2)
Pyridines (2)
Sex hormones (2)
Systemic hormonal preparations (2)
Thiazolidinediones (2)

Suppliers

AK Scientific (2)
Matrix Scientific (1)
Oakwood Chemical (1)
Toronto Research Chemicals (1)
TCI Chemicals (1)

Pioglitazone (111025-46-8)  
Actos  ·  pioglitazone hydrochloride  ·  U72,107A
Pioglitazone (brand name Actos) is a prescription drug of the thiazolidinedione (TZD) class with hypoglycemic (antihyperglycemic, antidiabetic) action to treat diabetes. While pioglitazone does decrease blood sugar levels, studies on the main cardiovascular outcomes have not yielded statistically significant results. Its cardiovascular safety profile compares favorably with that of rosiglitazone, which was withdrawn from some markets after concerns about an increased risk of cardiac events.
rosiglitazone (122320-73-4)  
Rosiglitazone (trade name Avandia) is an antidiabetic drug in the thiazolidinedione class. It works as an insulin sensitizer, by binding to the PPAR in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug or for use in combination with metformin or with glimepiride.
Related searches
www.sigmaaldrich.com
Drugs acting on the genito-urinary system
CYP17A1 inhibitors
Anti-diabetic drugs
Six-membered rings
Hormonal agents